The disease progresses rapidly, and the incidence of AML shows an increasing trend with age. 1 According to data from the National Cancer Institute, it is estimated that approximately 19,940 patients were diagnosed with AML in 2020, of which approximately 11,180 died in the United States. 2 In recent years, with the continuous optimization of chemotherapy, supportive treatment and bone marrow transplantation, the complete remission rate and disease‐free survival of AML have been improved to some extent.
← all excerpts
Epigenetic silencing of E-cadherin gene induced by lncRNA MALAT-1 in acute myeloid leukaemia.
1
—
—